Related references
Note: Only part of the references are listed.The Composition of the Culture Medium Influences the β-1,3-Glucan Metabolism of Aspergillus fumigatus and the Antifungal Activity of Inhibitors of β-1,3-Glucan Synthesis
Cecile Clavaud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
In Vitro and In Vivo Activities of Posaconazole and Amphotericin B in a Murine Invasive Infection by Mucor circinelloides: Poor Efficacy of Posaconazole
Valentina Salas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Protein Binding: Do We Ever Learn?
Markus A. Zeitlinger et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Posaconazole in Human Serum: a Greater Pharmacodynamic Effect than Predicted by the Non-Protein-Bound Serum Concentration
Anders Lignell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Azole Resistance of Aspergillus fumigatus Biofilms Is Partly Associated with Efflux Pump Activity
Ranjith Rajendran et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus
Russell E. Lewis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Impact of cyp51A Mutations on the Pharmacokinetic and Pharmacodynamic Properties of Voriconazole in a Murine Model of Disseminated Aspergillosis
Eleftheria Mavridou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Liposomal Amphotericin B and Echinocandins as Monotherapy or Sequential or Concomitant Therapy in Murine Disseminated and Pulmonary Aspergillus fumigatus Infections
Jon A. Olson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Antifungal Activity of Micafungin in Serum
Jun Ishikawa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network
John W. Baddley et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds - Subcommittee on antifungal susceptibility testing (AFST) of the ESCMID European committee for antimicrobial susceptibility testing (EUCAST)
J. -L. Rodriquez Tudela et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Use of a serum-based antifungal susceptibility assay to predict the in vivo efficacy of novel echinocandin compounds
Katsuyuki Maki et al.
MICROBIOLOGY AND IMMUNOLOGY (2008)
Update on echinocandin antifungals
Carol A. Kauffman et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia
Charalampos Antachopoulos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Effects of serum on in vitro susceptibility testing of echinocandins
Zekaver Odabasi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology
Joseph Meletiadis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Serum differentially alters the antifungal properties of echinocandin drugs
Padmaja Paderu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species
Charalampos Antachopoulos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Serum repressing efflux pump CDR1 in Candida albicans
Yun-Liang Yang et al.
BMC MOLECULAR BIOLOGY (2006)
In vitro activity of a new triazole BAL4815, the active component of BAL8557 (the water-soluble prodrug), against Aspergillus spp.
PA Warn et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Human albumin promotes germination, hyphal growth and antifungal resistance by Aspergillus fumigatus
AG Rodrigues et al.
MEDICAL MYCOLOGY (2005)
Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors
QB Xiong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Caspofungin uptake is mediated by a high-affinity transporter in Candida albicans
P Paderu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model
D Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Experimental pulmonary aspergillosis due to Aspergillus terreus:: Pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B
TJ Walsh et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Comparative molecular dynamics simulations of amphotericin B-cholesterol/ergosterol membrane channels
M Baginski et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2002)
Serum stimulates growth of and proteinase secretion by Aspergillus fumigatus
AHT Gifford et al.
INFECTION AND IMMUNITY (2002)
Colorimetric assay for antifungal susceptibility testing of Aspergillus species
J Meletiadis et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Influence of human serum on antifungal pharmacodynamics with Candida albicans
GG Zhanel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Susceptibility testing of Aspergillus flavus:: Inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo
J Mosquera et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Invasive aspergillosis - Disease spectrum, treatment practices, and outcomes
TF Patterson et al.
MEDICINE (2000)
Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection
EM Johnson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Share Paper
